News Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E. Other stock markets 11:40:31 06/05/2024 am IST			5-day change	1st Jan Change
0.053 ^AUD	+8.16%		0.00%	-27.40%

04:12am	Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	MT
09/04	Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	07:42am	MT
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	09/04	MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02	CI
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%	12/02	MT
Lumos Diagnostics' Q4 Revenue Jumps 55%	31/01	MT
Australian Shares Rise Ahead of US Inflation Data	11/01	MT
Lumos Diagnostics Signs Development and IP Agreements with Hologic; Shares Up 24%	11/01	MT
Lumos Signs Major Development and IP Agreements with Hologic, Inc	11/01	CI
Lumos Diagnostics Raises AU$2.7 Million to Support US Launch of FebriDx, ViraDx; Shares Down 6%	30/23/30	MT
US FDA Grants Emergency Use Authorization for Lumos Diagnostics' ViraDx	11/23/11	MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30	CI
Lumos Diagnostics Secures Europe, Japan Patents for Core Camera Reader	16/23/16	MT
Lumos Diagnostics Expands FebriDx Market to Netherlands	16/23/16	MT
Lumos Diagnostics Announces Core Camera Reader Patent Granted in Europe and Japan	16/23/16	CI
Lumos Diagnostics Secures R&D Tax Rebate for Fiscal Year 2022	10/23/10	MT
Lumos Diagnostics Signs Partnership with Henry Schein Medical for FebriDx Distribution; Shares Jump 8%	18/23/18	MT
Lumos Diagnostics Holdings Limited Appoints Doug Ward to Board as Managing Director	13/23/13	CI
Lumos Diagnostics Secures US FDA Clearance for Bacterial Respiratory Infection Test	03/23/03	MT
Lumos Diagnostics Secures AU$9 Million in Funding from New Agreements With US Healthcare Company	16/23/16	MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/23/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Summary

Filters